한글목차

세계의 신경보철 시장 규모는 2022년 50억 달러, 2023년 54억 달러에서 예측 기간 중 8.3%의 CAGR로 추이하며, 2028년에는 81억 달러 규모로 성장할 것으로 예측됩니다.

제품 유형별로는 인공와우 부문이 22022년 15억 달러, 2023년 16억 달러에서 5.2%의 CAGR로 추이하며, 2028년에는 21억 달러 규모로 성장할 것으로 예측됩니다. 또한 방광·장 제어 임플란트 부문은 2022년 9억 6770만 달러, 2023년 11억 달러에서 11.6%의 CAGR로 추이하며, 2028년에는 19억 달러 규모로 성장할 것으로 예측됩니다.

세계의 신경보철 시장을 조사했으며, 시장 및 기술의 개요, 시장 영향요인 분석, 법규제 환경, 시장 규모의 추이·예측, 각종 구분·지역별 상세 분석, 기술 및 특허의 동향, ESG 개발, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 요약·하이라이트

제3장 시장 개요

• 개요와 정의
• 신경보철
• 신경보철의 필요성
• 신경보철의 유형
• 인공와우
• 운동 회복을 위한 신경보철
• 뇌심부 자극 기기(DBS)
• 방광·장 제어 임플란트
• 인공 시각
• 규제 상황
• 미국
• 유럽

제4장 시장 역학

• 촉진요인
• 양호한 인구통계 동향
• 기술의 진보
• 규제기관에 의한 지원
• 높아지는 비용 절감 압력
• 바이오 의료 연구를 위한 강고한 자금조달 환경
• 미침투 시장
• 과제
• 고비용
• 기술적 과제
• 안전성의 우려
• 프라이버시와 설명 책임에 관한 우려
• 일관성 없는 상환 정책
• 시장에 영향을 미치는 주요 요인

제5장 시장 내역 : 제품 유형별

• 시장 개요
• 인공와우
• DBS
• DBS 승인 적응증
• 방광·장 제어 임플란트
• 천골신경 자극기(SNS)
• 경골신경 자극기(TNS)
• 운동 회복을 위한 신경보철
• 기능적 전기 자극(FES)
• 브레인/컴퓨터 인터페이스(BCI)
• 신경 제어 의지
• 근전 보철
• 뇌제어 의지
• 의지에서 BCI 기술의 현황
• 기타
• 인공 시각·인공 망막
• 횡격막 페이싱 시스템/횡격 신경자극기
• 시장 매출 : 제품 유형별
• 인공와우
• 인공와우 : 지역별 매출
• 뇌심부 자극 기기(DBS)
• DBS : 지역별 매출
• 운동 회복을 위한 신경보철
• 운동 회복을 위한 신경보철 : 지역별 매출
• 방광·장 제어 임플란트
• 방광·장 제어 임플란트 : 지역별 매출
• 기타
• 기타 : 지역별 매출

제6장 시장 내역 : 용도별

• 시장 개요
• 신경계 기능의 대체
• 신경계 조절
• 시장 매출 : 용도별
• 신경계 기능의 대체
• 시장 매출 : 지역별
• 신경계 조절
• 시장 매출 : 지역별

제7장 시장 내역 : 지역별

• 시장 개요
• 시장 매출 : 지역별
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제8장 ESG 개발

• ESG : 서론
• 신경보철 업계의 지속가능성 : ESG의 시점
• ESG의 주요 과제
• 업계의 ESG 퍼포먼스 분석
• BCC에 의한 결론

제9장 신규 기술과 개발

• 개요
• 뇌제어 의지
• 감각을 갖춘 보철
• AI를 활용한 신경보철
• 네트워크화된 신경보철 시스템
• 소형 디바이스와 무선 접속과 급전

제10장 임상시험

• 개요
• 인공와우
• 운동 회복을 위한 신경보철
• 브레인 컴퓨터 인터페이스(BCI)
• 기능적 전기 자극(FES)
• 뇌심부 자극 기기(DBS)
• 방광·장 제어 임플란트
• 기타

제11장 경쟁 정보

• 개요
• 인공와우
• 기업의 시장 점유율
• 시장 리더의 제품 포트폴리오
• 뇌심부 자극 기기(DBS)
• 기업의 시장 점유율
• 시장 리더의 제품 포트폴리오
• 방광·장 제어 임플란트
• 기업의 시장 점유율
• 시장 리더의 제품 포트폴리오
• 운동 회복을 위한 신경보철
• 주요 기업의 제품 포트폴리오
• 기타
• M&A

제12장 기업 개요

• ABBOTT LABORATORIES
• AXONICS INC.
• BIOVENTUS
• BLACKROCK NEUROTECH
• BOSTON SCIENTIFIC CORP.
• COCHLEAR LTD.
• CYBERDYNE INC.
• MED-EL MEDICAL ELECTRONICS
• MEDTRONIC
• NEUROPACE INC.
• PARADROMICS
• SONOVA
• SYNCHRON
• VIVANI MEDICAL INC.

제13장 부록

영문목차

Highlights:

The global neuroprosthetics market reached $5.0 billion in 2022, should reach $5.4 billion by 2023 and $8.1 billion by 2028 with a compound annual growth rate (CAGR) of 8.3% during the forecast period of 2023-2028.

Cochlear implants segment of the global neuroprosthetics market reached $1.5 billion in 2022, should reach $1.6 billion by 2023 and $2.1 billion by 2028 with a CAGR of 5.2% during the forecast period of 2023-2028.

Bladder and bowel control implants segment of the global neuroprosthetics market reached $967.7 million in 2022, should reach $1.1 billion by 2023 and $1.9 billion by 2028 with a CAGR of 11.6% during the forecast period of 2023-2028.

Report Scope:

This research study aims to thoroughly assess and analyze the neuroprosthetics market, revenue forecasts and future trends, globally, and to provide strategic recommendations for the success of market participants. The scope of the study is global. Current and projected market forecasts during the forecast period (2023 to 2028) are discussed. Figures for 2023 are estimated, except where actual results have been reported. This report includes forecasts by product type, application and region from 2023 through 2028.

This report also includes an analysis of leading and emerging competitors in the worldwide neuroprosthetics market. Profiles of leading product manufacturers and emerging players with novel products in development are also analyzed. This report assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment.

Report Includes:

• 32 data tables and 49 additional tables
• A comprehensive overview and an up-to-date analysis of the global market for Neuroprosthetics
• Analyses of the global market trends, with historical market revenue data (sales figures) for 2022, estimates for 2023, forecasts for 2024 and 2026, and projections of compound annual growth rates (CAGRs) through 2028
• Estimation of the actual market size and revenue forecast for global neuroprosthetics market in USD million values, and corresponding market share analysis based on product, type of stimulation technology, application, and region
• In-depth information (facts and figures) concerning the major factors influencing the progress of this market (benefits, and industry-specific challenges) with respect to specific growth trends, upcoming technologies, future prospects, and contributions to the overall market
• Discussion of ESG developments in Neuroprosthetics market, and an understanding of the importance of ESG, consumer attitudes towards sustainability, risks and opportunity assessment, and ESG followed practices by product manufacturers and industry participants
• A relevant patent analysis with significant allotments of key patent grants on Neuroprosthetics
• Review of the recent merger and acquisition (M&A) activities, venture fundings, and other impactful strategies contributing to the growth of this market
• Identification of leading and emerging competitors in the worldwide neuroprosthetics market, and analysis of competitive landscape based on recent developments, segmental revenues, and operational integration
• Company profiles of major players within the industry, including Abbott Laboratories, Boston Scientific Corp., Cochlear Ltd., Medtronic, and Sonova

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Methodology and Information Sources
• Geographic Breakdown

Chapter 2 Summary and Highlights

• Market Outlook
• Market Summary

Chapter 3 Market Overview

• Overview and Definitions
• Neuroprosthetics
• Need for Neuroprosthetics
• Types of Neuroprosthetics
• Cochlear Implants
• Neuroprosthetics for Movement Restoration
• Deep Brain Stimulators (DBS)
• Bladder and Bowel Control Implants
• Visual Prosthetics
• Regulatory Landscape
• U.S.
• Europe

Chapter 4 Market Dynamics

• Drivers
• Favorable Demographic Trends
• Technological Advancements
• Support from Regulatory Agencies
• Increasing Pressure to Cut Costs
• Robust Funding Environment for Biomedical Research
• Unpenetrated Market
• Challenges
• High Cost
• Technological Challenges
• Safety Concerns
• Privacy and Accountability Concerns
• Inconsistent Reimbursement Policies
• Key Factors Impacting Market

Chapter 5 Market Breakdown by Product Type

• Market Overview
• Cochlear Implants
• Deep Brain Stimulators
• Approved Indications for Deep Brain Stimulation Therapy
• Bladder and Bowel Control Implants
• Sacral Nerve Stimulators (SNSs)
• Tibial Nerve Stimulators (TNSs)
• Neuroprosthetics for Movement Restoration
• Neuroprosthetics for Movement Restoration
• Functional Electrical Stimulation (FES)
• Brain/Computer Interface (BCI)
• Neural-controlled Prosthetic Limbs
• Myoelectric Prostheses
• Brain-controlled Prosthetic Limbs
• Current State of BCI Technology in Prosthetics
• Others
• Visual Prosthetics/Retinal Prosthetics
• Diaphragm Pacing System/Phrenic Nerve Stimulator
• Market Revenue by Product Type
• Cochlear Implants
• Cochlear Implants Market Revenue by Region
• Deep Brain Stimulators (DBS)
• DBS Market Revenue by Region
• Neuroprosthetics for Movement Restoration
• Neuroprosthetics for Movement Restoration Market Revenue by Region
• Bladder and Bowel Control Implants
• Bladder and Bowel Control Implants: Market Revenue by Region
• Others
• Others Market Revenue by Region

Chapter 6 Market Breakdown by Application

• Market Overview
• Nervous System Function Replacement
• Nervous System Modulation
• Market Revenue by Application
• Nervous System Function Replacement
• Market Revenue by Region
• Nervous System Modulation
• Market Revenue by Region

Chapter 7 Market Breakdown by Region

• Market Overview
• Market Revenue by Region
• North America
• Reimbursement and Insurance Coverage
• Innovation Hub and Robust Funding
• Encouraging Regulatory Environment
• Market Demand and Adoption
• Market Revenue by Product Type
• Market Revenue by Application
• Market Revenue by Country
• Europe
• Market Revenue by Product Type
• Market Revenue by Application
• Market Revenue by Country
• Asia-Pacific
• Market Revenue by Product Type
• Market Revenue by Application
• Market Revenue by Country
• Rest of the World (RoW)
• Market Revenue by Product Type
• Market Revenue by Application

Chapter 8 ESG Development

• Introduction to ESG
• Sustainability in the Neuroprosthetics Industry: An ESG Perspective
• Key ESG Issues
• Industry ESG Performance Analysis
• Concluding Remarks from BCC

Chapter 9 Emerging Technologies and Development

• Overview
• Brain Controlled Prosthetics
• Prosthesis with Sensations
• Artificial Intelligence (AI) Powered Neuroprosthetics
• Networked Neuroprosthesis System
• Miniaturized Devices and Wireless Connectivity and Powering

Chapter 10 Clinical Trials

• Overview
• Cochlear Implants
• Neuroprosthetics for Movement Restoration
• Brain Computer Interface (BCI)
• Functional Electrical Stimulation (FES)
• Deep Brain Stimulators (DBS)
• Bladder and Bowel Control Implants
• Others

Chapter 11 Competitive Intelligence

• Overview
• Cochlear Implants
• Company Market Shares
• Market Leader Product Portfolio
• Deep Brain Stimulators (DBS)
• Company Market Shares
• Market Leader Product Portfolio
• Bladder and Bowel Control Implants
• Company Market Shares
• Market Leader Product Portfolio
• Neuroprosthetics for Movement Restoration
• Key Companies Product Portfolio
• Others
• Mergers and Acquisitions (M&A)

Chapter 12 Company Profiles

• ABBOTT LABORATORIES
• AXONICS INC.
• BIOVENTUS
• BLACKROCK NEUROTECH
• BOSTON SCIENTIFIC CORP.
• COCHLEAR LTD.
• CYBERDYNE INC.
• MED-EL MEDICAL ELECTRONICS
• MEDTRONIC
• NEUROPACE INC.
• PARADROMICS
• SONOVA
• SYNCHRON
• VIVANI MEDICAL INC.

Chapter 13 Appendix